Robinhood Markets, Inc.’s TransCode Therapeutics RNAZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$168 Buy
+102
New +$425 ﹤0.01% 1035

Other funds holding RNAZ

Robinhood Markets, Inc.'s RNAZ Position: Q3 2026 in Review

Robinhood Markets, Inc. opened a new position in TransCode Therapeutics (RNAZ) in Q3 2026: 102 shares worth $168. The stake represents ﹤0.01% of the portfolio and ranks #1035 among its holdings.

13 funds tracked by Wall St. Rank hold RNAZ as of Q3 2026.

  • Robinhood Markets, Inc. held 102 shares of TransCode Therapeutics worth $168 as of Q3 2026.
  • TransCode Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
  • TransCode Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1035 holding.
  • 13 funds tracked by Wall St. Rank held TransCode Therapeutics as of Q3 2026.

Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.